Suppr超能文献

博茨瓦纳 HIV 阳性个体的神经认知障碍:一项初步研究。

Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.

机构信息

Center for AIDS Research, University of Pennsylvania, Philadelphia, PA, USA.

Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

J Int AIDS Soc. 2010 Apr 20;13:15. doi: 10.1186/1758-2652-13-15.

Abstract

BACKGROUND

The primary objective of this study was to determine the prevalence of neurocognitive impairment among HIV-positive individuals in Botswana, using the International HIV Dementia Scale (IHDS). We also compared performance on the IHDS with performance on tests of verbal learning/memory and processing speed, and investigated the association between performance on the IHDS and such variables as depression, age, level of education and CD4 count.

METHODS

We conducted a cross-sectional study of 120 HIV-positive individuals randomly selected from an outpatient HIV clinic in Gaborone, Botswana. Patients provided a detailed clinical history and underwent neuropsychological testing; measures of depression, daily activities and subjective cognitive complaints were recorded.

RESULTS

Despite the fact that 97.5% of subjects were receiving highly active antiretroviral therapy (HAART), 38% met criteria for dementia on the IHDS, and 24% were diagnosed with major depressive disorder. There was a significant association between neurocognitive impairment as measured by the IHDS and performance on the other two cognitive measures of verbal learning/memory and processing speed. Level of education significantly affected performance on all three cognitive measures, and age affected processing speed and performance on the IHDS. Depression and current CD4 count did not affect performance on any of the cognitive measures.

CONCLUSIONS

The prevalence of neurocognitive impairment in HIV-positive individuals in Botswana is higher than expected, especially since almost all of the subjects in this study were prescribed HAART. This suggests the need to reconsider the timing of introduction of antiretroviral therapy in developing countries where HAART is generally not administered until the CD4 cell count has dropped to 200/mm3 or below. The contribution of other factors should also be considered, such as poor central nervous system penetration of some antiretrovirals, drug resistance, potential neurotoxicity, and co-morbidities. Memory impairment and poor judgment may be underlying causes for behaviours that contribute to the spread of HIV and to poor adherence. It is important to identify these neurobehavioural complications of HIV so that effective treatments can be developed.

摘要

背景

本研究的主要目的是使用国际艾滋病毒痴呆量表(IHDS),确定博茨瓦纳艾滋病毒阳性个体的神经认知障碍患病率。我们还比较了 IHDS 与言语学习/记忆和处理速度测试的表现,并调查了 IHDS 表现与抑郁、年龄、教育程度和 CD4 计数等变量之间的关系。

方法

我们对博茨瓦纳哈博罗内一家门诊艾滋病毒诊所的 120 名随机选择的艾滋病毒阳性个体进行了横断面研究。患者提供了详细的临床病史并接受了神经心理学测试;记录了抑郁、日常活动和主观认知抱怨的测量结果。

结果

尽管 97.5%的受试者正在接受高效抗逆转录病毒治疗(HAART),但 38%的受试者符合 IHDS 的痴呆标准,24%的受试者被诊断为重度抑郁症。IHDS 测量的神经认知障碍与言语学习/记忆和处理速度的其他两项认知测试的表现之间存在显著关联。教育程度显著影响所有三项认知测试的表现,年龄影响处理速度和 IHDS 的表现。抑郁和当前 CD4 计数对任何认知测试的表现均无影响。

结论

博茨瓦纳艾滋病毒阳性个体的神经认知障碍患病率高于预期,尤其是考虑到本研究中的几乎所有受试者都接受了 HAART 治疗。这表明需要重新考虑在发展中国家引入抗逆转录病毒治疗的时间,因为在 CD4 细胞计数降至 200/mm3 或以下之前,通常不会在这些国家使用 HAART。还应考虑其他因素的贡献,例如一些抗逆转录病毒药物对中枢神经系统的穿透率低、耐药性、潜在的神经毒性和合并症。记忆障碍和判断力差可能是导致 HIV 传播和治疗依从性差的行为的潜在原因。重要的是要识别出这些 HIV 的神经行为并发症,以便开发有效的治疗方法。

相似文献

1
Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
J Int AIDS Soc. 2010 Apr 20;13:15. doi: 10.1186/1758-2652-13-15.
3
4
Neurocognitive Disorders in HIV-positive Patients.
J Assoc Physicians India. 2023 Jun;71(6):11-12. doi: 10.5005/japi-11001-0272.
6
Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.
J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):488-92. doi: 10.1097/QAI.0b013e3181b06348.
7
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
BMC Infect Dis. 2019 Feb 13;19(1):156. doi: 10.1186/s12879-019-3784-y.
8
Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
J Neuroimmune Pharmacol. 2017 Dec;12(4):661-669. doi: 10.1007/s11481-017-9748-3. Epub 2017 May 3.
9
Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
AIDS Patient Care STDS. 2018 Jan;32(1):1-8. doi: 10.1089/apc.2017.0202.
10
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
J Neurol Sci. 2009 Oct 15;285(1-2):149-53. doi: 10.1016/j.jns.2009.06.043. Epub 2009 Jul 24.

引用本文的文献

6
Neurocognitive Impairment and Associated Factors Among People Living with HIV: A Systematic Review and Meta-Analysis of African Studies.
Neuropsychiatr Dis Treat. 2023 Mar 28;19:673-687. doi: 10.2147/NDT.S377636. eCollection 2023.
7
Factors associated with verbal fluency in older adults living with HIV in West Africa: A longitudinal study.
Trop Med Int Health. 2023 Jan;28(1):35-42. doi: 10.1111/tmi.13830. Epub 2022 Dec 7.
8
Providing differentiated service delivery to the ageing population of people living with HIV.
J Int AIDS Soc. 2022 Sep;25 Suppl 4(Suppl 4):e26002. doi: 10.1002/jia2.26002.
9
Worldwide Occurrence of HIV-Associated Neurocognitive Disorders and Its Associated Factors: A Systematic Review and Meta-Analysis.
Front Psychiatry. 2022 May 31;13:814362. doi: 10.3389/fpsyt.2022.814362. eCollection 2022.

本文引用的文献

1
Depression among HIV-positive individuals in Botswana: a behavioral surveillance.
AIDS Behav. 2011 Jan;15(1):204-8. doi: 10.1007/s10461-009-9622-2.
2
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.
Neuropsychol Rev. 2009 Jun;19(2):169-85. doi: 10.1007/s11065-009-9092-3. Epub 2009 May 9.
4
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.
AIDS Res Hum Retroviruses. 2008 Oct;24(10):1301-7. doi: 10.1089/aid.2007.0310.
5
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region.
Neurology. 2008 Jul 1;71(1):50-6. doi: 10.1212/01.wnl.0000316390.17248.65.
6
Two-year prospective study of major depressive disorder in HIV-infected men.
J Affect Disord. 2008 Jun;108(3):225-34. doi: 10.1016/j.jad.2007.10.017. Epub 2007 Nov 28.
7
Updated research nosology for HIV-associated neurocognitive disorders.
Neurology. 2007 Oct 30;69(18):1789-99. doi: 10.1212/01.WNL.0000287431.88658.8b. Epub 2007 Oct 3.
8
Subjective memory complaints, mood, and memory deficits among HIV/AIDS patients in Hong Kong.
J Clin Exp Neuropsychol. 2008 Apr;30(3):338-48. doi: 10.1080/13803390701416189. Epub 2007 Jul 25.
9
Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.
J Clin Exp Neuropsychol. 2008 Jan;30(1):83-90. doi: 10.1080/13803390701233865. Epub 2007 Apr 20.
10
Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.
J Neurovirol. 2007 Aug;13(4):291-304. doi: 10.1080/13550280701422383.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验